Definitive hypofractionated radiation therapy for early stage breast cancer: Dosimetric feasibility of stereotactic ablative radiotherapy and proton beam therapy for intact breast tumors.

Adv Radiat Oncol · 2018 · PMC6128030 · PMID 30202812

Europe PMC DOI

hedged sentence

0.0810

closest p · 1.6× alpha

0.0810

boldest claim

The sentences

a nonsignificant trendP = .081so close (0.05 < p ≤ 0.1)

There was a nonsignificant trend toward improvement with PBT versus 3-dimensional CRT in maximum skin doses ( P = .081).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.